Digestive Diseases and Sciences publishes editorial review of clinical data supporting Peppermint Oil in IBgard delivery system — 4 things to know

On Dec. 21, 2015, Digestive Disease and Sciences published an editorial review titled, “Treating Irritable Bowel Syndrome: A Fresh and Minty Approach to an Old Therapy.” The editorial reviewed the clinical data from an online article titled, “A Novel Delivery System of Peppermint Oil is an Effective Therapy for Irritable Bowel Syndrome Symptoms.”

Advertisement

The review supports the novel delivery system of Peppermint Oil in IBgard, a medical food for irritable bowel syndrome.

Here are four things to know:

1. Lucinda Harris, MD, author of the editorial and associate professor of medicine in gastroenterology at the Mayo Clinic in Scottsdale, Ariz., said, “Not only were global (IBS symptom) scores significantly improved at 24 hours (19.6 percent vs. 10.3 percent) and at four weeks (40 percent vs. 24.3 percent), but additionally four out of eight secondary endpoints (abdominal pain, bloating/distension, pain at evacuation and urgency) were significantly improved.”

2. Dr. Harris also commented on the possible advantage in efficacy and tolerability of the novel delivery system for peppermint oil in IBgard.

3. The IBSREST supports the body of evidence supporting the use of peppermint oil in the management of IBS.

4. One in six Americans suffers from IBS.

More articles on GI/endoscopy:
GI physician leader to know: Dr. David Alpers of Washington University at St. Louis
Frozen vs. fresh fecal matter for FMT — Does it make a difference? 4 insights
Midwest Gastroenterology adds Dr. Richard Lozoff — 3 points

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.